Full Text View
Tabular View
No Study Results Posted
Related Studies
Phase III Study of Chondrocyte Alginate Gel Suspension in Pediatric Patients With Vesicoureteral Reflux
This study is ongoing, but not recruiting participants.
Study NCT00004487   Information provided by FDA Office of Orphan Products Development
First Received: October 18, 1999   Last Updated: June 23, 2005   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Vesicoureteral Reflux
Additional conditions recognized in this trial
Vesico-Ureteral Reflux
More general conditions related to this trial
Urinary Bladder Diseases
Urologic Diseases
Interventions listed in this trial
chondrocyte-alginate gel suspension
Additional drug interventions recognized in this trial
Alginic acid
More general drug interventions related to this trial
Coagulants
Hematologic Agents
Hemostatics
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Radiation-Protective Agents
Therapeutic Uses
Sponsors listed in this trial
FDA Office of Orphan Products Development
Curis, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services